The uricosuric agent probenecid is indicated in gout patients who require urate-lowering therapy, underexcrete uric acid, and are intolerant of allopurinol. In this retrospective study from a rheumatology clinic in New Zealand, researchers describe their experience with this drug.
Of 521 gout patients in this clinic, …